University of ZürichZurich, Zurich, Switzerland
17 - Seladelpar Treatment Resulted in Correlated Decreases in Serum IL-31 and Pruritus in Patients with Primary Biliary Cholangitis (PBC): Post-Hoc Results from the Phase 3 Randomized, Placebo-Controlled ENHANCE Study
Monday, October 23, 20232:35 PM – 2:45 PM PT
